Paloma Partners Management CO Aclaris Therapeutics, Inc. Transaction History

Paloma Partners Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.01 - $1.36 $79,992 - $107,712	79,200 New	79,200 $87,000
Q3 2020 Nov 16, 2020	SELL	$1.5 - $2.71 $107,700 - $194,578	-71,800 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.04 - $1.73 $74,672 - $124,214	71,800 New	71,800 $116,000
Q1 2020 May 15, 2020	SELL	$0.75 - $2.18 $10,987 - $31,937	-14,650 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.02 - $1.97 $14,943 - $28,860	14,650 New	14,650 $28,000
Q3 2019 Nov 14, 2019	SELL	$0.79 - $2.47 $16,195 - $50,635	-20,500 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$2.13 - $7.06 $852 - $2,824	-400 Reduced 1.91%	20,500 $45,000
Q1 2019 May 15, 2019	BUY	$5.63 - $7.84 $117,667 - $163,856	20,900 New	20,900 $125,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.